Plasma Protein Binding of Drugs in the Elderly

Abel JG, Sellers EM, Naranjo CA, Shaw J, Kadar D, et al. Inter- and intrasubject variation in diazepam free fraction. Clinical Pharmacology and Therapeutics 26: 247–255, 1979 Åberg-Wistedt A, Jostell KG, Ross SB, Westerlund D. Effects of zimelidine and desipramine on serotonin and nor-adrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression. Psycho-pharmacology 74: 297–305, 1981 Abernethy DR, Greenblatt DJ, Shader RI. Imipramine and desipramine disposition in the elderly. Journal of Pharmacology and Experimental Therapeutics 232: 183–232, 1985 Adir J, Miller AK, Vestal RE. Effects of total plasma concentration and age on tolbutamide plasma protein binding. Clinical Pharmacology and Therapeutics 32: 488–493, 1982 Allen MD, Greenblatt DJ. Comparative protein binding of diazepam and desmethyldiazepam. Journal of Clinical Pharmacology 21: 219–223, 1981 Allen MD, Greenblatt DJ, Harmatz JS, Shader RI. Desmethyldiazepam kinetics in the elderly after oral prazepam. Clinical Pharmacology and Therapeutics 28: 196–202, 1980 Alván G, Bergström K, Borgå O, Iselius L, Pedersen N. Family study of genetic and environmental factors determining the protein binding of propranolol. European Journal of Clinical Pharmacology 25: 437–441, 1983 Andreasen F, Hansen U, Husted SE, Jansen JA. The pharmacokinetics of frusemide are influenced by age. British Journal of Clinical Pharmacology 16: 391–397, 1983 Antal EJ, Kramer PA, Mercik SA, Chapron DJ, Lawson IR. Theophylline pharmacokinetics in advanced age. British Journal of Clinical Pharmacology 12: 637–645, 1981 Barber HE, Hawksworth GM, Petrie JC, Rigby JW, Robb OJ, et al. Pharmacokinetics of atenolol and propranolol in young and elderly subjects. British Journal of Clinical Pharmacology 11: 118P–119P, 1981 Bauer LA, Davis R, Wilensky A, Raisys V, Levy RH. Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults. Clinical Pharmacology and Therapeutics 37: 697–704, 1985 Bendayan R, Pieper JA, Stewart RB, Caranasos GJ. Influence of age on serum protein binding of propranolol. European Journal of Clinical Pharmacology 26: 251–254, 1984 Bender AD, Post A, Meier JP, Higson JE, Reichard G. Plasma protein binding of drugs as a function of age. Journal of Pharmaceutical Sciences 64: 1711–1713, 1975 Blain PG, Mucklow JC, Rawlins MD, Roberts DF, Routledge PA, et al. Determinants of plasma α1-acid glycoprotein (AGP) concentrations in health. British Journal of Clinical Pharmacology 20: 500–502, 1985 Blanchard J. Protein binding of caffeine in young and elderly males. Journal of Pharmaceutical Sciences 71: 1415–1418, 1982 Blaschke TF. Protein binding and kinetics of drugs in liver diseases. Clinical Pharmacokinetics 2: 32–44, 1977 Bonde J, Pedersen LE, Bødtker S, Angelo HR, Svendsen TL, et al. The influence of age and smoking on the elimination of disopyramide. British Journal of Clinical Pharmacology 20: 453–458, 1985 Bower S. Plasma protein binding of fentanyl. Journal of Pharmacy and Pharmacology 33: 507–514, 1981 Bower S. Plasma protein binding of fentanyl: the effect of hyperlipoproteinemia and chronic renal failure. Journal of Pharmacy and Pharmacology 34: 102–106, 1982 Braithwaite RA, Heard R, Snape A. Plasma protein binding of maprotiline in geriatric patients — influence of α1-acid glycoprotein. British Journal of Clinical Pharmacology 6: 448P–449P, 1978 Bredesen JE, Kierulf P. Relationship between α1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyl disopyramide. British Journal of Clinical Pharmacology 18: 779–784, 1984 Brinkschulte M, Breyer-Pfaff U. Binding of tricyclic anti-depressants and perazine to human plasma. Naunyn-Schmiedeberg’s Archives of Pharmacology 308: 1–7, 1979 Bryson SM, Kelly JC, Kelman AW, Whiting B. Therapeutic free Phenytoin monitoring. Clinical Pharmacokinetics 9(Suppl. 1): 90, 1984 Burch J, Robert SG, Raddats MA. Binding of amitriptyline and nortriptyline in plasma determined from their equilibrium distributions between red cells and plasma and between red cells and buffer solution. Psychopharmacology 75: 262–272, 1981 Carlos R, Calvo R, Erill S. Plasma protein binding of etomidate in different age groups and in patients with chronic respiratory insufficiency. International Journal of Clinical Pharmacology, Therapy and Toxicology 19: 171–174, 1981 Chan K, Kendall MJ, Mitchard M, Walls WDE, Vickers MD. The effect of ageing on plasma pethidine concentration. British Journal of Clinical Pharmacology 2: 297–302, 1975 Chapron DJ, Sweeney KR, Feig PU, Kramer PA. Influence of advanced age on the disposition of acetazolamide. British Journal of Clinical Pharmacology 19: 363–371, 1985 Christensen JH, Andreasen F, Jansen JA. Influence of age and sex on the pharmacokinetics of thiopentone. British Journal of Anaesthesiology 53: 1189–1195, 1981 Cusack B, O’Malley K, Lavan J, Noel J, Kelly JG. Protein binding and disposition of lignocaine in the elderly. European Journal of Clinical Pharmacology 29: 323–329, 1985 Cutler NR, Narang PK, Lesko U, Ninos M, Power M. Vancomycin disposition: the importance of age. Clinical Pharmacology and Therapeutics 36: 803–809, 1984 Davis D, Grossman SH, Kitchell BB, Shand DG, Routledge PA. The effect of age and smoking on the plasma protein binding of lignocaine and diazepam. British Journal of Clinical Pharmacology 19: 261–265, 1985 Dehlin O, Björnsson G, Lundström J. Zimelidine to geriatric patients: a pharmacokinetic and clinical study. Acta Psychiatrica Scandinavica 63(Suppl. 290): 410–424, 1981 Divoll M, Greenblatt DJ. Effect of age and sex on lorazepam protein binding. Journal of Pharmacy and Pharmacology 34: 122–123, 1982 Divoll M, Greenblatt DJ, Harmatz JS, Shader RI. Effect of age and gender on disposition of temazepam. Journal of Pharmaceutical Sciences 70: 1104–1107, 1981 Feely J, Crooks J, Stevenson IH. The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentrations. Clinical Pharmacology and Therapeutics 12: 73–78, 1981 Gal P, Oles KS, Baird WH. Phenytoin and carbamazepine serum protein binding in a geriatric patient population. Clinical Pharmacokinetics 9(Suppl. 1): 92–93, 1984 Greenblatt DJ. Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program. Journal of the American Geriatric Society 27: 20–22, 1979 Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, et al. Effect of age, gender and obesity on midazolam kinetics. Anesthesiology 61: 27–45, 1984a Greenblatt DJ, Abernethy DR, Locniskar A, Ochs HR, Harmatz JS, et al. Age, sex and nitrazepam kinetics: relation to antipyrine disposition. Clinical Pharmacology and Therapeutics 38: 697–703, 1985a Greenblatt DJ, Abernethy DR, Matlis R, Harmatz JS, Shader RI. Absorption and disposition of ibuprofen in the elderly. Arthritis and Rheumatism 27: 1066–1069, 1984b Greenblatt DJ, Allen MD, Harmatz JS, Shader RI. Diazepam disposition determinants. Clinical Pharmacy and Therapeutics 27: 302–312, 1980a Greenblatt DJ, Divoll M, Abernethy DR, Moschitto LJ, Smith RB, et al. Alprazolam kinetics in the elderly: relation to antipyrine disposition. Archives of General Psychiatry 40: 287–290, 1983a Greenblatt DJ, Divoll M, Abernethy DR, Moschitto LJ, Smith RB, et al. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. British Journal of Clinical Pharmacology 15: 303–309, 1983b Greenblatt DJ, Divoll M, Harmatz JS, MacLaughlin DS, Shader RI. Kinetics and clinical effects of flurazepam in young and elderly noninsomniacs. Clinical Pharmacology and Therapeutics 30: 475–486, 1981a Greenblatt DJ, Divoll M, Harmatz JS, Shader RI. Oxazepam kinetics: effects of age and sex. Journal of Experimental Pharmacology and Therapeutics 215: 86–91, 1980b Greenblatt DJ, Divoll M, Puri SK, Ho I, Zinny MA, et al. Clobazam kinetics in the elderly. British Journal of Clinical Pharmacology 12: 631–636, 1981b Greenblatt DJ, Matlis R, Scavone JM, Blyden GT, Harmatz JS, et al. Oxaprozin kinetics in the elderly. British Journal of Clinical Pharmacology 19: 373–378, 1985b Hayes MJ, Langman MJS, Short AH. Changes in drug metabolism with increasing age. 1. Warfarin binding and plasma proteins. British Journal of Clinical Pharmacology 2: 69–72, 1975a Hayes MJ, Langman MJS, Short AH. Changes in drug metabolism with increasing age. 2. Phenytoin clearance and protein binding. British Journal of Clinical Pharmacology 2: 73–79, 1975b Hayes MJ, Sprackling M, Langman MJS. Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effects. Gut 18: 1054–1058, 1977 Ho PC, Bourne DWA, Triggs EJ, Smithhurst BA. Comparison of plasma levels of canrenone and metabolites after base hydrolysis in young and elderly subjects following single and multiple doses of spironolactone. European Journal of Clinical Pharmacology 27: 435–439, 1984 Holmberg L, Odar-Cederlöf I, Nilsson JLG, Ehrnebo M, Boréus LO. Pethidine binding to blood cells and plasma proteins in old and young subjects. European Journal of Clinical Pharmacology 23: 457–461, 1982 Holt DW, Hayler AM, Healey GF. Effect of age and plasma concentration of albumin and α1-acid glycoprotein on protein binding of disopyramide. British Journal of Clinical Pharmacology 16: 344–345, 1983 Hooper WD, Bochner F, Eadie MJ, Tyrer JH. Plasma protein binding of diphenylhydantoin. Clinical Pharmacology and Therapeutics 15: 276–282, 1974 Jochemsen R, Nandi KL, Corless D, Wesselman JGJ, Breimer DD. Pharmacokinetics of brotizolam in the elderly. British Journal of Clinical Pharmacology 16: 299S–307S, 1983a Jochemsen R, Van Beusekom BR, Spoelstra P, Janssens AR, Breimer DD. Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam. British Journal of Clinical Pharmacology 15: 295–302, 1983b Johnson RF, Schenker S, Roberts RK, Desmond PV, Wilkinson GR. Plasma binding of benzodiazepines in humans. Journal of Pharmaceutical Sciences 68: 1320–1322, 1979 Johnston A, Hamer J. Serum protein binding of disopyramide. British Journal of Clinical Pharmacology 13: 288P–289P, 1982 Jung D, Mayersohn M, Perrier D, Calkins J, Saunders R. Thiopental disposition as a function of age in female patients undergoing surgery. Anaesthesiology 56: 263–268, 1982 Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. Journal of Clinical Investigation 55: 347–359, 1975 Knott C, Bateman M, Reynolds F. Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined. British Journal of Clinical Pharmacology 17: 9–14, 1984 Kraus JW, Desmond PV, Marshall JP, Johnson RF, Schenker S, et al. Effects of aging and liver disease on disposition of lorazepam. Clinical Pharmacology and Therapeutics 24: 411–419, 1978 Kristensen CB. Imipramine serum protein binding in healthy subjects. Clinical Pharmacology and Therapeutics 34: 689–694, 1983 Kroboth PD, Smith RB, Sorkin MI, Silver MR, Rault R, et al. Triazolam protein binding and correlation with alpha-1-acid glycoprotein concentration. Clinical Pharmacology and Therapeutics 36: 379–383, 1984 Lesko LJ, Narang PK, Yeager L, Cutler NR. Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration. European Journal of Clinical Pharmacology 28: 339–345, 1985 Lesko LJ, Tabor KJ, Johnson BF. Theophylline serum protein binding in obstructive airways disease. Clinical Pharmacology and Therapeutics 29: 776–781, 1981 Luderer JR, Patel IH, Durkin J, Schneck DW. Age and ceftriaxone kinetics. Clinical Pharmacology and Therapeutics 35: 19–25, 1984 Macklon AF, Barton M, James O, Rawlins MD. The effect of age on the pharmacokinetics of diazepam. Clinical Science 59: 479–483, 1980 Mather LE, Tucker GT, Pflug AE, Lindop MJ, Willarson C. Meperidine kinetics in man. Clinical Pharmacology and Therapeutics 17: 21–30, 1975 Nation RL, Vine J, Triggs EJ, Learoyd B. Plasma levels of chlormethiazole and two metabolites after oral administration to young and aged human subjects. European Journal of Clinical Pharmacology 12: 137–145, 1977 Netter P, Faure G, Regent MC, Procknal JA, Levy G. Salicylate kinetics in old age. Clinical Pharmacology and Therapeutics 38: 6–11, 1985 Norbury HM, Franklin RA, Graham DF. Pharmacokinetics of the new analgesic, meptazinol after oral and intravenous administration to volunteers. European Journal of Clinical Pharmacology 25: 77–80, 1983 Norbury HM, Franklin RA, Graham DF, Sinha B. Pharmacokinetics of meptazinol after single and multiple oral administration to elderly patients. European Journal of Clinical Pharmacology 27: 223–226, 1984 Norbury HM, Franklin RA, Graham DF, Sinha B. Pharmacokinetics of meptazinol after single and multiple oral administration to elderly patients. European Journal of Clinical Pharmacology 27: 223–226, 1984 Nyberg G, Axelsson R, Mårtensson E. Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients. European Journal of Clinical Pharmacology 14: 341–350, 1978 Ochs HR, Greenblatt DJ, Divoll M, Abernethy DR, Feyerabend H, et al. Diazepam kinetics in relation to age and sex. Pharmacology 23: 24–30, 1981 Ochs HR, Greenblatt DJ, Woo E, Smith TW. Reduced quinidine clearance in elderly persons. American Journal of Cardiology 42: 481–485, 1978 Patel L, Johnston A, Turner P. Nadolol binding to human serum proteins. J. Pharm. Pharmacol. 36: 414–415, 1984 Patterson M, Heazelwood R, Smithhurst B, Eadie MJ. Plasma protein binding of Phenytoin in the aged: in vivo studies. British Journal of Clinical Pharmacology 13: 423–425, 1982 Paxton JW. Alpha1-acid glycoprotein and binding of basic drugs. Methods and Findings in Experimental and Clinical Pharmacology 5: 635–648, 1983 Paxton JW, Briant RH. α1-Acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness. British Journal of Clinical Pharmacology 18: 806–810, 1984 Perucca E, Grimaldi R, Gotti G, Pirracchio S, Crema F, et al. Pharmacokinetics of valproic acid in the elderly. British Journal of Clinical Pharmacology 17: 665–669, 1984 Peterson GM, McLean S, Aldous S, Von Witt RJ, Millingen KS. Plasma protein binding of Phenytoin in 100 epileptic patients. British Journal of Clinical Pharmacology 14: 298–300, 1982 Piafsky KM. Disease-induced changes in the plasma binding of basic drugs. Clinical Pharmacokinetics 5: 246–262, 1980 Reidenberg MM, Drayer DE. Alteration of drug-protein binding in renal disease. Clinical Pharmacokinetics 9(Suppl. 1): 18–26, 1984 Richardson CJ, Blocka KLN, Ross SG, Verbeeck RK. Effect of age and sex on piroxicam disposition. Clinical Pharmacology and Therapeutics 37: 13–18, 1985 Rigby JW, Scott AK, Hawksworth GM, Petrie JC. A comparison of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young subjects. British Journal of Clinical Pharmacology 20: 327–331, 1985 Roberts MS, Rumble RH, Wanwimolruk S, Thomas D, Brooks PM. Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease. European Journal of Clinical Pharmacology 25: 253–261, 1983 Roberts RK, Wilkinson GR, Branch RA, Schenker S. Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (Librium). Gastroenterology 75: 479–485, 1978 Romach MK, Piafsky KM, Abel JG, Khouw V, Sellers EM. Methadone binding to orosomucoid (α1-acid glycoprotein): determinant of free fraction in plasma. Clinical Pharmacology and Therapeutics 29: 211–217, 1981 Rowell FJ, Hui SM, Fairbairn AF, Eccleston D. The effect of age and thioridazine on the in vitro binding of fluphenazine to normal human serum. British Journal of Clinical Pharmacology 9: 432–433, 1980 Rowell FJ, Hui SM, Fairbairn AF, Eccleston D. Total and free serum haloperidol levels in schizophrenic patients and the effect of age, thioridazine and fatty acids on haloperidol serum protein binding in vitro. British Journal of Clinical Pharmacology 11: 377–382, 1981 Rowland M. Protein binding and drug clearance. Clinical Pharmacokinetics 9(Suppl. 1): 10–17, 1984 Sager G, Hansteen V, Aakesson I, Jacobsen S. Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction. British Journal of Clinical Pharmacology 12: 613–620, 1981 Schulz P, Turner-Tamiyasu K, Smith G, Giacomini KM, Blaschke TF. Amitriptyline disposition in young and elderly normal men. Clinical Pharmacology and Therapeutics 33: 360–366, 1983 Shader RI, Greenblatt DJ, Cirraulo DA, Divoll M, Harmatz JS, et al. Effect of age and sex on disposition of desmethyldiazepam formed from its precursor clorazepate. Psychopharmacology 75: 193–197, 1981 Shepherd AMM, Hewick DS, Moreland TA, Stevenson IH. Age as a determinant of sensitivity to warfarin. British Journal of Clinical Pharmacology 4: 315–320, 1977 Tedeschi G, Bianchetti S, Henry JF, Braithwaite RA, Mikulic E, et al. Influence of age and disease states on the plasma protein binding of haloperidol. British Journal of Clinical Pharmacology 11: 430P, 1981 Tillement JP, Lhoste F, Giudicelli JF. Diseases and drug protein binding. Clinical Pharmacokinetics 3: 144–154, 1978 Tozer TN. Implications of altered plasma protein binding in disease states. In Benet LZ (Eds) Pharmacokinetic basis for drug treatment, pp. 173–193, Raven Press, New York, 1984 Upton RA, Williams RL, Kelly J, Jones RM. Naproxen pharmacokinetics in the elderly. British Journal of Clinical Pharmacology 18: 207–214, 1984 Varoquaux O, LaJoie D, Gobart C, Cordonnier P, Ducreuzet C, et al. Pharmacokinetics of the trimethoprim-sulphamethoxazole combination in the elderly. British Journal of Clinical Pharmacology 20: 575–581, 1985 Verbeeck RK, Cardinal JA, Wallace SM. Effect of age and sex on the plasma binding of acidic and basic drugs. European Journal of Clinical Pharmacology 27: 91–97, 1984 Verbeeck RK, De Schepper PJ. Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding. Clinical Pharmacology and Therapeutics 27: 628–635, 1980 Vestal RE. Aging and pharmacokinetics: impact of altered physiology in the elderly. In Cherkin et al. (Eds) Physiology and cell biology of aging, pp. 185–201, Raven Press, New York, 1979 Virtanen R, Kanto J, Iisalo E, Salo M, Sjövall S. Pharmacokinetic studies on atropine with special reference to age. Acta Anaesthesiologica Scandinavica 26: 297–300, 1982 Wallace S, Whiting B, Runcie J. Factors affecting drug binding in plasma of elderly patients. British Journal of Clinical Pharmacology 3: 327–330, 1976 Yosselson-Superstine S, Yanuka Y, Ishai S. Relationship between quinidine concentrations measured in saliva and erythrocytes and in serum. International Journal of Clinical Pharmacology, Therapy and Toxicology 20: 181–186, 1982 Yost RL, Devane GL. Diurnal variations of α1-acid glycoprotein concentrations in normal volunteers. Journal of Pharmaceutical Sciences 74: 777–779, 1985